Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host DiseaseBadri Modi, Ryotaro Nakamura, Karen M. Huelsman et al.|Biology of Blood and Marrow Transplantation|2018Cited by 84
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Vinod Pullarkat, Sanjeet Dadwal et al.|Blood Advances|2019Cited by 84
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet Sandhu, Vinod Pullarkat, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2020Cited by 43